Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease.
GlaxoSmithKline says HPV vaccine worked in studyCourtesy Newsvine - business Tue, 07/07/2009 - 11:37
Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease. Tags:
Related itemsFDA approves Glaxo's cervical cancer vaccine
Glaxo AIDS Drug Has 'Spectacular' Results in Study
Struggling biotech Epix Pharmaceuticals goes bust
NNTN4930A Original OEM Motorola Nextel i830 Lithium...
HP 02 Black Twin Pack Ink Cartridge with Vivera Ink
|
Popular by tags Week
Month |
Post new comment